Identification of bisindolylmaleimides and indolocarbazoles as inhibitors of HCV replication by tube-capture-RT-PCR

Yuko Murakami, Kohji Noguchi, Satoshi Yamagoe, Tetsuro Suzuki, Takaji Wakita, Hidesuke Fukazawa

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

We devised a screening method for hepatitis C virus (HCV) inhibitors by exploiting the JFH1 viral culture system. The viral RNA released in the medium was adsorbed onto PCR plates, and real-time RT-PCR was performed by directly adding the one-step RT-PCR reaction mixture to the wells. The "tube-capture-RT-PCR" method obviates the need for labor-intensive RNA isolation and should allow high-throughput screening of HCV inhibitors. To substantiate the validity of the assay for drug screening, a pilot screen of an inhibitor library composed of 95 compounds was performed. In addition to the known inhibitors of HCV replication included in the library, the assay identified the PKC inhibitor bisindolylmaleimide I (BIM I) as an HCV replication inhibitor. BIM I was also effective in reducing the viral protein level in genotype 1b and 2a subgenomic replicon cells, indicating inhibition of HCV replication. Further assays revealed that a broad range of bisindolylmaleimides and indolocarbazoles inhibit HCV, but no correlation was found between the PKC inhibition pattern and anti-HCV activity. These series of compounds represent new classes of inhibitors that may warrant further development.

Original languageEnglish
Pages (from-to)112-117
Number of pages6
JournalAntiviral Research
Volume83
Issue number2
DOIs
Publication statusPublished - 2009 Aug
Externally publishedYes

Fingerprint

Virus Replication
Hepacivirus
Polymerase Chain Reaction
Libraries
Replicon
Preclinical Drug Evaluations
Viral RNA
Viral Proteins
bisindolylmaleimide
Real-Time Polymerase Chain Reaction
Genotype
RNA

Keywords

  • Bisindolylmaleimide
  • HCV
  • High-throughput
  • Tube-capture-RT-PCR

ASJC Scopus subject areas

  • Virology
  • Pharmacology

Cite this

Identification of bisindolylmaleimides and indolocarbazoles as inhibitors of HCV replication by tube-capture-RT-PCR. / Murakami, Yuko; Noguchi, Kohji; Yamagoe, Satoshi; Suzuki, Tetsuro; Wakita, Takaji; Fukazawa, Hidesuke.

In: Antiviral Research, Vol. 83, No. 2, 08.2009, p. 112-117.

Research output: Contribution to journalArticle

Murakami, Yuko ; Noguchi, Kohji ; Yamagoe, Satoshi ; Suzuki, Tetsuro ; Wakita, Takaji ; Fukazawa, Hidesuke. / Identification of bisindolylmaleimides and indolocarbazoles as inhibitors of HCV replication by tube-capture-RT-PCR. In: Antiviral Research. 2009 ; Vol. 83, No. 2. pp. 112-117.
@article{42d36a15c6c342f1b3f30b02d89d80c7,
title = "Identification of bisindolylmaleimides and indolocarbazoles as inhibitors of HCV replication by tube-capture-RT-PCR",
abstract = "We devised a screening method for hepatitis C virus (HCV) inhibitors by exploiting the JFH1 viral culture system. The viral RNA released in the medium was adsorbed onto PCR plates, and real-time RT-PCR was performed by directly adding the one-step RT-PCR reaction mixture to the wells. The {"}tube-capture-RT-PCR{"} method obviates the need for labor-intensive RNA isolation and should allow high-throughput screening of HCV inhibitors. To substantiate the validity of the assay for drug screening, a pilot screen of an inhibitor library composed of 95 compounds was performed. In addition to the known inhibitors of HCV replication included in the library, the assay identified the PKC inhibitor bisindolylmaleimide I (BIM I) as an HCV replication inhibitor. BIM I was also effective in reducing the viral protein level in genotype 1b and 2a subgenomic replicon cells, indicating inhibition of HCV replication. Further assays revealed that a broad range of bisindolylmaleimides and indolocarbazoles inhibit HCV, but no correlation was found between the PKC inhibition pattern and anti-HCV activity. These series of compounds represent new classes of inhibitors that may warrant further development.",
keywords = "Bisindolylmaleimide, HCV, High-throughput, Tube-capture-RT-PCR",
author = "Yuko Murakami and Kohji Noguchi and Satoshi Yamagoe and Tetsuro Suzuki and Takaji Wakita and Hidesuke Fukazawa",
year = "2009",
month = "8",
doi = "10.1016/j.antiviral.2009.03.008",
language = "English",
volume = "83",
pages = "112--117",
journal = "Antiviral Research",
issn = "0166-3542",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Identification of bisindolylmaleimides and indolocarbazoles as inhibitors of HCV replication by tube-capture-RT-PCR

AU - Murakami, Yuko

AU - Noguchi, Kohji

AU - Yamagoe, Satoshi

AU - Suzuki, Tetsuro

AU - Wakita, Takaji

AU - Fukazawa, Hidesuke

PY - 2009/8

Y1 - 2009/8

N2 - We devised a screening method for hepatitis C virus (HCV) inhibitors by exploiting the JFH1 viral culture system. The viral RNA released in the medium was adsorbed onto PCR plates, and real-time RT-PCR was performed by directly adding the one-step RT-PCR reaction mixture to the wells. The "tube-capture-RT-PCR" method obviates the need for labor-intensive RNA isolation and should allow high-throughput screening of HCV inhibitors. To substantiate the validity of the assay for drug screening, a pilot screen of an inhibitor library composed of 95 compounds was performed. In addition to the known inhibitors of HCV replication included in the library, the assay identified the PKC inhibitor bisindolylmaleimide I (BIM I) as an HCV replication inhibitor. BIM I was also effective in reducing the viral protein level in genotype 1b and 2a subgenomic replicon cells, indicating inhibition of HCV replication. Further assays revealed that a broad range of bisindolylmaleimides and indolocarbazoles inhibit HCV, but no correlation was found between the PKC inhibition pattern and anti-HCV activity. These series of compounds represent new classes of inhibitors that may warrant further development.

AB - We devised a screening method for hepatitis C virus (HCV) inhibitors by exploiting the JFH1 viral culture system. The viral RNA released in the medium was adsorbed onto PCR plates, and real-time RT-PCR was performed by directly adding the one-step RT-PCR reaction mixture to the wells. The "tube-capture-RT-PCR" method obviates the need for labor-intensive RNA isolation and should allow high-throughput screening of HCV inhibitors. To substantiate the validity of the assay for drug screening, a pilot screen of an inhibitor library composed of 95 compounds was performed. In addition to the known inhibitors of HCV replication included in the library, the assay identified the PKC inhibitor bisindolylmaleimide I (BIM I) as an HCV replication inhibitor. BIM I was also effective in reducing the viral protein level in genotype 1b and 2a subgenomic replicon cells, indicating inhibition of HCV replication. Further assays revealed that a broad range of bisindolylmaleimides and indolocarbazoles inhibit HCV, but no correlation was found between the PKC inhibition pattern and anti-HCV activity. These series of compounds represent new classes of inhibitors that may warrant further development.

KW - Bisindolylmaleimide

KW - HCV

KW - High-throughput

KW - Tube-capture-RT-PCR

UR - http://www.scopus.com/inward/record.url?scp=67349114573&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349114573&partnerID=8YFLogxK

U2 - 10.1016/j.antiviral.2009.03.008

DO - 10.1016/j.antiviral.2009.03.008

M3 - Article

C2 - 19549584

AN - SCOPUS:67349114573

VL - 83

SP - 112

EP - 117

JO - Antiviral Research

JF - Antiviral Research

SN - 0166-3542

IS - 2

ER -